Company Filing History:
Years Active: 2022
Title: Louis Patrick Lessard: Innovator in Alpha-Amylase Variants
Introduction: Louis Patrick Lessard is a notable inventor based in Wake Forest, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of alpha-amylase variants. His work has implications for various industrial applications, showcasing the importance of innovation in enzyme technology.
Latest Patents: Lessard holds a patent for "Alpha-amylase variants and polynucleotides encoding same." This invention relates to alpha-amylase variants that include specific substitutions at positions corresponding to positions 268 and 293 of SEQ ID NO: 1. The variants exhibit a high degree of sequence identity to parent alpha-amylases, making them valuable for various applications. The patent highlights the potential for these variants to be utilized in different biotechnological processes.
Career Highlights: Louis Patrick Lessard is currently associated with Novozymes A/S, a leading company in the field of enzyme production. His work at Novozymes has allowed him to focus on innovative solutions that enhance the efficiency of industrial processes. With 1 patent to his name, Lessard continues to contribute to advancements in enzyme technology.
Collaborations: Throughout his career, Lessard has collaborated with esteemed colleagues such as Carsten Schau Andersen and Lars Giger. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.
Conclusion: Louis Patrick Lessard's contributions to the development of alpha-amylase variants exemplify the impact of innovation in biotechnology. His work not only advances scientific understanding but also has practical applications in various industries.